Biovations⢠has developed a platform microfluidic technology for wide-spread, point-of-care, genetic mutation detection with applications in numerous markets. Genetic mutations are the most abundant class of polymorphism and predispose individuals to specific diseases and influence their response to drugs. Genetic testing identifies individuals who have predisposition to diseases before the onset of the symptoms. Biovationsâ¢, technology offers the potential to transform the field of personalized medicine by extending genetic testing into the clinical laboratory and doctor's office. Biovationsâ¢â thermoelectric DNA sequencing technology is protected by U.S.
